Diametric Capital’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Diametric Capital’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-99,295	Closed	-$189K	–	365
2023 Q4	$189K	Sell	99,295 -23,658	-19%	-$35.3K	0.11%	208
2023 Q3	$162K	Buy	122,953 +98,726	+408%	+$217K	0.07%	286
2023 Q2	$72.4K	Buy	24,227 +10,303	+74%	+$33.1K	0.03%	297
2023 Q1	$48.2K	Sell	13,924 -23,032	-62%	-$112K	0.02%	306
2022 Q4	$154K	Buy	36,956 +7,934	+27%	+$30K	0.07%	245
2022 Q3	$116K	Sell	29,022 -990	-3%	-$7.51K	0.06%	234
2022 Q2	$339K	Buy	+30,012	New	+$360K	0.25%	143

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

EAM

Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

EPL

EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Diametric Capital's NBP Position: Q1 2024 in Review

Diametric Capital sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2024, closing a stake of 99,295 shares — an estimated $189K sold.

Diametric Capital first reported a position in NBP in Q2 2022 and held it in 7 quarters. The position peaked at $339K in Q2 2022. 39 funds tracked by Wall St. Rank hold NBP as of Q1 2024.

Diametric Capital reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Diametric Capital sold 99,295 NovaBridge Biosciences American Depositary Shares shares in Q1 2024, an estimated $189K.
Diametric Capital first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2022 and held it in 7 quarters.
Diametric Capital's NovaBridge Biosciences American Depositary Shares position peaked at $339K in Q2 2022.
39 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2024.

Based on Diametric Capital's 13F filing for Q1 2024, filed 15 May 2024.